HomeOpen Access NewsDrug Development

Drug Development

iDOMO: New AI tool predicts synergistic drug combinations

Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex diseases like cancer.

Bharat Biotech COVID vaccine shows 81% efficacy at Phase Three

The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.

Scientists find that elevated neutrophils can predict severe COVID and death

Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.

Israel will now vaccinate Palestinians who have permits to work 

Israel faced international criticism on their refusal to vaccine Palestinians - now, the country will begin rolling out Pfizer shots to some Palestinians who have work permits.

FDA approves the Johnson & Johnson vaccine for use

The US Food and Drug Administration (FDA) approved the Johnson & Johnson vaccine, with an efficacy of 86%, as the next to be rolled out across the US.

The window for convalescent plasma donation is just under two months

New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.

Pfizer vaccine can reduce COVID hospitalisation and death by 75%

Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.

Science needs to overcome “structural racism” to end the HIV epidemic

A new report published in The Lancet investigates why 43% of HIV deaths in 2018 happened in the Black community, with policy solutions for the ongoing HIV epidemic.

REACT study: COVID cases in hospitals “higher than at the peak of the first wave”

New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.

The Johnson & Johnson COVID vaccine works with just one dose

The New Jersey-based drugmaker created a COVID-19 vaccine that works at 66% efficiency in one dose, which they have sent to the EU for approval.

70% of available COVID vaccines in 2021 have been pre-ordered

Currently, 16% of the global population have pre-ordered 70% of available COVID vaccines in 2021 - a group of virus experts now warn that COVID will keep evolving unless low income countries can access vaccines.

Existing drugs could be used to fight COVID-19 in elderly patients

A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.

How will everyone benefit if WTO members sign the TRIPS COVID-19 waiver?

Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the TRIPS COVID-19 waiver rejected by the WTO could ramp up global vaccine production.

What are the side effects of the AstraZeneca vaccine?

Here, we use science to dissect some of the rumours about the side effects of the AstraZeneca and Oxford University vaccine.

Scientists identify possible drug to fight incurable childhood cancer

Diffuse Intrinsic Pontine Glioma (DIPG) is an incurable childhood cancer that has no effective treatment - but now, scientists in Australia believe they have found a drug that could begin to treat this cancer.

Scientists saw COVID mutating in patient after convalescent plasma

UK based scientists witnessed how COVID-19 can mutate in a highly vulnerable patient, even when that person is undergoing convalescent plasma treatment.

Scientists invent AI that creates COVID vaccine candidates within seconds

Scientists usually take months to analyse potential mutations of the virus, but this new AI can create COVID vaccine candidates within seconds.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders